Γρήγορη απάντηση
Artesunate — Artesunate 50/60/120 mg (WHO-GMP certified manufacturer). Artemisinin derivative for severe falciparum malaria (IV first-line WHO recommendation), uncomplicated malaria (oral artesunate-mefloquine combinations), occasional research use in oncology (off-label, unproven).
Αυτό που λαμβάνετε με την MedsBase:
- πιστοποιημένο από τη WHO-GMP κατασκευαστή
- Συσκευασία σε απλό φάκελο χωρίς ενδείξεις
- Παγκόσμια αποστολή
- Αξιολογήθηκε από 1,400+ πελάτες (διαβάστε κριτικές)
📦 Εγγύηση Επαναποστολής: αν η παραγγελία σας δεν έχει φτάσει μέσα σε 20 εργάσιμες ημέρες από την αποστολή, την επαναποστέλλουμε χωρίς πρόσθετο κόστος. Διαβάστε την πολιτική.
Γιατί να παραγγείλετε από τη MedsBase
Artesunate ships from a WHO-GMP certified manufacturer in plain packaging, billed through a regulated payment processor (the statement descriptor reads a regulated card-payment processor — never MedsBase or any medication name). Every order carries our 20-business-day Reshipment Assurance.
⚠️ Specialist-supervised cancer therapy — this medication is started, monitored, and stopped by an oncologist or haematologist. Dosing depends on tumour type, stage, body surface area, organ function, and concomitant therapy. Self-treatment is not appropriate; the information below is educational and supports informed conversations with your specialist.
Artesunate is a first-line antimalarial agent. Off-label cancer research is investigational and not standard care. For severe malaria, IV artesunate replaced quinine as WHO first-line in 2010 (SEAQUAMAT, AQUAMAT trials). Specialist infectious disease supervision for severe disease.
Συχνές Ερωτήσεις
When is this used?
Artemisinin derivative for severe falciparum malaria (IV first-line WHO recommendation), uncomplicated malaria (oral artesunate-mefloquine combinations), occasional research use in oncology (off-label, unproven).
Side effects?
Class-specific — see safety boxes above. Most supportive cancer medications are well-tolerated when used per protocol but require specialist supervision.
Αλληλεπιδράσεις φαρμάκων;
Always disclose all medications. Cancer supportive therapy interacts with multiple cytotoxics, chemo regimens, and concomitant medications.
Εγκυμοσύνη;
Variable by molecule. Consult oncology for pregnancy planning during cancer therapy.
Monitoring?
Specialist-determined — typically FBC, electrolytes, renal/liver function, cardiac monitoring as relevant.
Τι γίνεται αν χάσω μια δόση;
Take when you remember; do not double up. Discuss with oncology team if multiple doses missed.
When is treatment finished?
Determined by clinical response, planned regimen length, and patient tolerance.
Storage?
Per package insert — typically below 25-30°C, away from light and moisture. Pregnant household members should not handle broken tablets/capsules.
Cost?
Generic Indian biosimilars and chemical equivalents are dramatically less expensive than originator products with documented bioequivalence and clinical equivalence.
Vaccines?
Coordinate with oncology — live vaccines may be contraindicated during cancer therapy.
Other Cancer & Supportive Medications
- Xeloda — capecitabine 500 mg — oral 5-FU prodrug for breast/colorectal/gastric cancers
- Altraz — anastrozole 1 mg — aromatase inhibitor for post-menopausal breast cancer
- Xbira — abiraterone 250 mg — CYP17 inhibitor for metastatic prostate cancer
- Zoldria — zoledronic acid IV — for bone metastases and hypercalcaemia
- Actorise — darbepoetin alfa — for chemotherapy-induced anaemia

























Κριτικές
Δεν υπάρχουν ακόμη κριτικές